Wall Street Close: Stocks ended mixed after vaccine roll-out
|- The Dow Jones Industrial Average fell 0.62% to end at 29,859.97 points.
- The S&P 500 SPX lost 0.44% to 3,647.33.
- The Nasdaq Composite climbed 0.5% to 12,440.04.
Despite the roll-out of the COVID-19 vaccine campaign in the United States, US stocks were mixed by the close.
The Dow Jones Industrial Average touched a record high before ending lower,
A Pfizer PFE and its German partner BioNTechBNTX began on Monday to administer the vaccine following emergency-use approval from federal regulators last week.
The S&P 500 gave up earlier gains of almost 1%. Unofficially, the Dow Jones Industrial Average lost 0.62% to end at 29,859.97 points, while the S&P 500 SPX fell 0.44% to 3,647.33. The Nasdaq Composite added 0.5% to 12,440.04.
Meanwhile, additional coronavirus relief remains elusive after the Senate last week approved a one-week extension of federal funding to avoid a government shutdown.
Investors were also focused on early voting in a pair of US Senate races in Georgia that will determine control of the chamber and heavily influence lawmaking. The latter will help determine the future path of Biden’s fiscal policy.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.